Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 2
1957 1
1962 1
1964 1
1965 3
1966 3
1967 1
1968 5
1969 5
1970 6
1971 5
1972 6
1973 3
1974 8
1975 13
1976 9
1977 15
1978 8
1979 10
1980 16
1981 7
1982 18
1983 7
1984 14
1985 8
1986 11
1987 17
1988 15
1989 17
1990 19
1991 15
1992 14
1993 23
1994 18
1995 12
1996 14
1997 11
1998 16
1999 6
2000 17
2001 17
2002 15
2003 15
2004 13
2005 18
2006 12
2007 8
2008 19
2009 12
2010 17
2011 23
2012 15
2013 23
2014 22
2015 22
2016 20
2017 24
2018 30
2019 30
2020 41
2021 27
Text availability
Article attribute
Article type
Publication date

Search Results

764 results
Results by year
Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: lund b. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: lund b. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS, Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM, Benigno B, Arora S, Hazard SJ, Mirza MR. Del Campo JM, et al. Among authors: lund b. J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173551 Free PMC article. Clinical Trial.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Oza AM, Matulonis UA, Malander S, Hudgens S, Sehouli J, Del Campo JM, Berton-Rigaud D, Banerjee S, Scambia G, Berek JS, Lund B, Tinker AV, Hilpert F, Vázquez IP, D'Hondt V, Benigno B, Provencher D, Buscema J, Agarwal S, Mirza MR. Oza AM, et al. Among authors: lund b. Lancet Oncol. 2018 Aug;19(8):1117-1125. doi: 10.1016/S1470-2045(18)30333-4. Epub 2018 Jul 17. Lancet Oncol. 2018. PMID: 30026000 Clinical Trial.
[Hip arthroscopy].
Lund B, Søballe K, Winge S, Hølmich P, Jacobsen S, Lind M. Lund B, et al. Ugeskr Laeger. 2011 Jan 17;173(3):197-200. Ugeskr Laeger. 2011. PMID: 21241628 Review. Danish.
[Younger patients with hip joint pain].
Dippmann C, Albrecht-Olsen P, Boesen M, Chrintz H, Hölmich P, Jakobsen SS, Jørgensen U, Konradsen L, Kraemer O, Lund B, Maagaard N, Mygind-Klavsen B, Overgaard S, Ovesen O, Stürup J, Søballe K, Warming T, Winther N, Krogsgaard M. Dippmann C, et al. Among authors: lund b. Ugeskr Laeger. 2020 Jan 6;182(2):V06180432. Ugeskr Laeger. 2020. PMID: 31928620 Review. Danish.
[Femoroacetabular impingement syndrome].
Ishøi L, Kraemer O, Klavsen BM, Lund B. Ishøi L, et al. Among authors: lund b. Ugeskr Laeger. 2019 Feb 18;181(8):V09180653. Ugeskr Laeger. 2019. PMID: 30821233 Danish.
764 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page